#155: Genetic subtypes in MS. What they mean for your progression and treatment with Dr. Karim Kreft
Genetic subtypes in MS may help explain why the disease progresses differently from person to person. In this interview, Dr. Karim Kreft shares how genetic clustering could one day support more personalized treatment decisions. While clinical use is still in the future, the direction toward biologically guided MS care is clear.
#100: The Future of MS Care. Can Digital Twins Predict Your Disease Progression? With Prof. Tjalf Ziemssen
The concept of a digital twin is revolutionizing medicine, offering a new way to personalize treatments and predict disease progression. But what exactly does it mean for multiple sclerosis patients? In the 100th anniversary episode of the English MS-Perspektive Podcast, Prof. Tjalf Ziemssen, one of the world’s leading MS experts and innovators, explains how AI […]
#086: Navigating Menopause with MS – Key insights on symptom progression, aging, and personalized care (ECTRIMS Special)
Find out how the menopause affects MS. What new research reveals about progression, symptom management, biological aging and quality of life.
